vs
Side-by-side financial comparison of Fabrinet (FN) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.3× Fabrinet). Fabrinet runs the higher net margin — 9.9% vs -13.6%, a 23.5% gap on every dollar of revenue. On growth, Fabrinet posted the faster year-over-year revenue change (35.9% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $-5.3M). Over the past eight quarters, Fabrinet's revenue compounded faster (24.4% CAGR vs -3.6%).
FabrinetFNEarnings & Financial Report
Below is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index sometimes contains more than 400 stocks when it includes two or more share classes of stock from one of its component companies.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
FN vs OGN — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.5B |
| Net Profit | $112.6M | $-205.0M |
| Gross Margin | 12.2% | 49.2% |
| Operating Margin | 10.1% | -9.8% |
| Net Margin | 9.9% | -13.6% |
| Revenue YoY | 35.9% | -5.3% |
| Net Profit YoY | 30.0% | -288.1% |
| EPS (diluted) | $3.11 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $978.1M | $1.6B | ||
| Q2 25 | $909.7M | $1.6B | ||
| Q1 25 | $871.8M | $1.5B | ||
| Q4 24 | $833.6M | $1.6B | ||
| Q3 24 | $804.2M | $1.6B | ||
| Q2 24 | $753.3M | $1.6B | ||
| Q1 24 | $731.5M | $1.6B |
| Q4 25 | $112.6M | $-205.0M | ||
| Q3 25 | $95.9M | $160.0M | ||
| Q2 25 | $87.2M | $145.0M | ||
| Q1 25 | $81.3M | $87.0M | ||
| Q4 24 | $86.6M | $109.0M | ||
| Q3 24 | $77.4M | $359.0M | ||
| Q2 24 | $81.1M | $195.0M | ||
| Q1 24 | $80.9M | $201.0M |
| Q4 25 | 12.2% | 49.2% | ||
| Q3 25 | 11.9% | 53.5% | ||
| Q2 25 | 12.2% | 54.8% | ||
| Q1 25 | 11.7% | 55.6% | ||
| Q4 24 | 12.1% | 56.3% | ||
| Q3 24 | 12.3% | 58.3% | ||
| Q2 24 | 12.3% | 58.4% | ||
| Q1 24 | 12.4% | 59.0% |
| Q4 25 | 10.1% | -9.8% | ||
| Q3 25 | 9.6% | 15.2% | ||
| Q2 25 | 9.8% | 14.4% | ||
| Q1 25 | 9.0% | 6.7% | ||
| Q4 24 | 9.5% | 8.1% | ||
| Q3 24 | 9.6% | 13.1% | ||
| Q2 24 | 9.7% | 14.6% | ||
| Q1 24 | 9.7% | 14.5% |
| Q4 25 | 9.9% | -13.6% | ||
| Q3 25 | 9.8% | 10.0% | ||
| Q2 25 | 9.6% | 9.1% | ||
| Q1 25 | 9.3% | 5.8% | ||
| Q4 24 | 10.4% | 6.8% | ||
| Q3 24 | 9.6% | 22.7% | ||
| Q2 24 | 10.8% | 12.1% | ||
| Q1 24 | 11.1% | 12.4% |
| Q4 25 | $3.11 | $-0.78 | ||
| Q3 25 | $2.66 | $0.61 | ||
| Q2 25 | $2.41 | $0.56 | ||
| Q1 25 | $2.25 | $0.33 | ||
| Q4 24 | $2.38 | $0.42 | ||
| Q3 24 | $2.13 | $1.38 | ||
| Q2 24 | $2.22 | $0.75 | ||
| Q1 24 | $2.21 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $960.8M | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $2.2B | $752.0M |
| Total Assets | $3.3B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $960.8M | $574.0M | ||
| Q3 25 | $968.8M | $672.0M | ||
| Q2 25 | $934.2M | $599.0M | ||
| Q1 25 | $950.7M | $547.0M | ||
| Q4 24 | $934.6M | $675.0M | ||
| Q3 24 | $908.9M | $763.0M | ||
| Q2 24 | $858.6M | $704.0M | ||
| Q1 24 | $794.0M | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $2.2B | $752.0M | ||
| Q3 25 | $2.1B | $906.0M | ||
| Q2 25 | $2.0B | $733.0M | ||
| Q1 25 | $1.9B | $542.0M | ||
| Q4 24 | $1.8B | $472.0M | ||
| Q3 24 | $1.8B | $493.0M | ||
| Q2 24 | $1.7B | $144.0M | ||
| Q1 24 | $1.7B | $48.0M |
| Q4 25 | $3.3B | $12.9B | ||
| Q3 25 | $3.0B | $13.6B | ||
| Q2 25 | $2.8B | $13.5B | ||
| Q1 25 | $2.6B | $13.2B | ||
| Q4 24 | $2.5B | $13.1B | ||
| Q3 24 | $2.4B | $12.8B | ||
| Q2 24 | $2.3B | $12.2B | ||
| Q1 24 | $2.2B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.3M | $141.0M |
| Free Cash FlowOCF − Capex | $-5.3M | $96.0M |
| FCF MarginFCF / Revenue | -0.5% | 6.4% |
| Capex IntensityCapex / Revenue | 4.6% | 3.0% |
| Cash ConversionOCF / Net Profit | 0.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $102.3M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.3M | $141.0M | ||
| Q3 25 | $102.6M | $264.0M | ||
| Q2 25 | $55.1M | $220.0M | ||
| Q1 25 | $74.2M | $75.0M | ||
| Q4 24 | $115.9M | $390.0M | ||
| Q3 24 | $83.2M | $141.0M | ||
| Q2 24 | $83.1M | $332.0M | ||
| Q1 24 | $100.9M | $76.0M |
| Q4 25 | $-5.3M | $96.0M | ||
| Q3 25 | $57.3M | $218.0M | ||
| Q2 25 | $4.7M | $181.0M | ||
| Q1 25 | $45.7M | $43.0M | ||
| Q4 24 | $94.0M | $335.0M | ||
| Q3 24 | $62.9M | $99.0M | ||
| Q2 24 | $70.4M | $300.0M | ||
| Q1 24 | $87.3M | $30.0M |
| Q4 25 | -0.5% | 6.4% | ||
| Q3 25 | 5.9% | 13.6% | ||
| Q2 25 | 0.5% | 11.4% | ||
| Q1 25 | 5.2% | 2.8% | ||
| Q4 24 | 11.3% | 21.0% | ||
| Q3 24 | 7.8% | 6.3% | ||
| Q2 24 | 9.3% | 18.7% | ||
| Q1 24 | 11.9% | 1.8% |
| Q4 25 | 4.6% | 3.0% | ||
| Q3 25 | 4.6% | 2.9% | ||
| Q2 25 | 5.5% | 2.4% | ||
| Q1 25 | 3.3% | 2.1% | ||
| Q4 24 | 2.6% | 3.5% | ||
| Q3 24 | 2.5% | 2.7% | ||
| Q2 24 | 1.7% | 2.0% | ||
| Q1 24 | 1.9% | 2.8% |
| Q4 25 | 0.41× | — | ||
| Q3 25 | 1.07× | 1.65× | ||
| Q2 25 | 0.63× | 1.52× | ||
| Q1 25 | 0.91× | 0.86× | ||
| Q4 24 | 1.34× | 3.58× | ||
| Q3 24 | 1.07× | 0.39× | ||
| Q2 24 | 1.02× | 1.70× | ||
| Q1 24 | 1.25× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
OGN
Segment breakdown not available.
